Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ABCA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBLCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL21A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF680 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
COL6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAU2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAQR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM49B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on